Nanoparticle Analysis Market Report 2026

The nanoparticle analysis market size has grown rapidly in recent years. It will grow from $5.77 billion in 2025 to $6.37 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to growing nanotechnology research, increasing pharmaceutical innovation, rising need for precision measurement, expanding academic research funding, early scientific exploration of nanomaterials.

The nanoparticle analysis market size is expected to see strong growth in the next few years. It will grow to $9.17 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing medical nanotechnology applications, rising demand for advanced analytical instruments, expansion of nanomaterial manufacturing, growing environmental monitoring needs, increasing investment in scientific research infrastructure. Major trends in the forecast period include rising adoption of advanced nanoparticle characterization techniques, increasing use of nanotechnology in pharmaceuticals and biotechnology, growing demand for high precision particle measurement solutions, expansion of research activities in nanoscience and material engineering, increasing utilization of nanoparticles in electronics and environmental studies.

The rising prevalence of cancer is expected to drive the growth of the nanoparticle analysis market in the coming years. Cancer encompasses a group of disorders characterized by abnormal cell proliferation that can invade and spread throughout the body. Factors contributing to the increasing prevalence of cancer include aging populations, lifestyle changes, environmental exposures, and advancements in detection and diagnosis methods. Nanoparticle analysis plays a critical role in advancing cancer research and treatment, enabling researchers to understand the unique properties of nanoparticles. This understanding supports the development of targeted drug delivery systems, improvements in cancer imaging, and the advancement of personalized medicine approaches. For example, in February 2024, according to the World Health Organization, a Switzerland-based international organization focused on global health policy and public health initiatives, over 35 million new cancer cases are projected by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is fueling growth in the nanoparticle analysis market.

Major companies in the nanoparticle analysis market are concentrating on developing real-time solutions for nanoparticle detection and analysis to enhance their competitive position. Nanoparticle detection and analysis solutions encompass technologies and methodologies utilized for detecting, characterizing, and analyzing nanoparticles, which typically range in size from 1 to 100 nanometers. For instance, in August 2023, Corning Inc., a US-based technology company, introduced Videodrop, an optical technology that revolutionizes real-time nanoparticle detection and analysis. Leveraging interferometric microscopy, this technology enables the rapid quantification of nanoparticle size and concentration in under 60 seconds, requiring just a 5-10 µl drop of sample material. Videodrop is capable of capturing physical titers of viral vectors such as lentivirus, retrovirus, adenovirus, and extracellular vesicles (EVs) within the 80-500 nanometers range. It serves as an invaluable in-process control tool throughout the purification process, furnishing real-time data to optimize bioprocessing workflows.

In September 2023, Sartorius AG, a Germany-based biopharmaceutical company, entered a partnership with SPARTA Biodiscovery to develop and commercialize SPARTA's innovative nanoparticle analysis platform. This collaboration aims to expedite the development, manufacturing, and quality control of nanoparticles used in gene therapies, vaccines, and cancer drugs. SPARTA Biodiscovery, a UK-based biopharmaceutical startup, specializes in providing nanoparticle analysis platforms, making it a strategic partner for advancing nanoparticle-based therapies.

Major companies operating in the nanoparticle analysis market report are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Beckman Coulter Inc., Shimadzu Corporation, Bruker Corporation, Malvern Panalytical Ltd., Horiba Ltd., Particle Measuring Systems Inc., Sympatec GmbH, TSI Incorporated, Micromeritics Instrument Corporation, EAG Laboratories, Anton Paar GmbH, Polytec GmbH, Quantum Design International, Wyatt Technology, Microtrac Inc., Aimsizer Scientific Ltd., Hitachi High-Tech Analytical Science, Brookhaven Instruments Corporation, Cordouan Technologies, Dispersion Technology Inc., Nanophoton Corporation.

North America was the largest region in the nanoparticle analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanoparticle analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nanoparticle analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nanoparticle analysis market consists of revenues earned by entities by providing services such as resonant mass measurement, x-ray diffraction and atomic force microscopy (AFM). The market value includes the value of related goods sold by the service provider or included within the service offering. The nanoparticle analysis market also includes sales of dynamic image analysis (DIA), surface plasmon resonance (SPR) spectroscopy, and inductively coupled plasma mass spectrometry (ICP-MS). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.